866-997-4948(US-Canada Toll Free)

Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 114 Pages

Notes:
Sales, means the sales volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies sales (consumption) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
Tobira Therapeutics
Verva Pharmaceuticals
Zafgen

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in each application, can be divided into
Application 1
Application 2

Table of Contents

Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2017
1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2022)
1.5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)
1.5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Manufacturers, Type and Application
2.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
2.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
2.2.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
2.2.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
2.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Countries
2.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries (2012-2017)
2.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
3.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
3.1.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
3.1.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
3.1.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
3.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
3.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
3.4 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
4.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
4.1.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
4.1.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
4.1.4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
4.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
4.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
4.4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

5 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
5.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
5.1.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
5.1.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
5.1.5 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
5.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
5.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
5.4 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

6 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
6.1.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
6.1.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
6.1.6 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
6.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

7 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
7.1.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
7.1.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
7.1.7 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
7.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

8 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
8.1.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
8.1.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
8.1.8 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
8.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
9.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
9.1.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
9.1.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
9.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
9.3 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
9.4 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

10 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
10.1 Conatus Pharmaceuticals
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Daewoong Pharmaceutical
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Galmed International
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Kyorin Pharmaceutical
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Metabolic Solutions Development
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Novartis AG
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Phenex Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Raptor Pharmaceuticals
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 TCM Biotech International
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Tobira Therapeutics
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Verva Pharmaceuticals
10.12 Zafgen

11 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis
11.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2017-2022)
14.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.4 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.5 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.6 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.7 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast (2017-2022)
14.8 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2022)
14.9 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Europe Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Europe Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Countries (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Countries (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2012-2017)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)
Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)
Table Verva Pharmaceuticals Basic Information List
Table Zafgen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2022)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *